Malaysia pacemaker market
is anticipated to witness a growth of steady CAGR during the forecast period. The
pacemaker market in Malaysia has witnessed a remarkable growth over the past
few years, owing to the increasing prevalence of cardiovascular disease and
cardiovascular surgeries in Malaysia.
Cardiovascular
disease (CVD) refers to a group of conditions that affect the heart and blood
vessels. According to the National Health and Morbidity Survey (NHMS)
conducted in 2019, the prevalence of CVD in Malaysia was 15.6%, up from 13.7%
in 2015. This increase is primarily due to the rise in the number of people
with hypertension (approximately 30% of Malaysians aged 18 years and above
are affected from hypertension, according to the Malaysian National Health and
Morbidity Survey 2019), diabetes (the diabetes prevalence in Malaysia
ranges from 7.3% to 23.8%, according to published reports), and obesity (according
to the National Health and Morbidity Survey (NHMS) 2019, Malaysia’s obesity
rate among 18 years and above is reported to be 19.7%), which are risk
factors for CVD.
In addition, the
number of cardiovascular surgeries in Malaysia has been on the rise in recent
years, primarily due to the increasing prevalence of CVD. According to the
Malaysian National Cardiovascular Disease Database (NCVD), the number of
cardiovascular surgeries performed in Malaysia increased from 10,790 in 2010 to
17,514 in 2018.
Also, rising
healthcare expenditure is driving the pacemaker market in Malaysia. The
Malaysian government has increased its healthcare expenditure in recent years,
with a focus on improving healthcare infrastructure and increasing access to
medical services. This has led to an increase in the number of hospitals and
healthcare facilities in the country, which has further increased the demand
for pacemakers, thereby expanding the Malaysia pacemaker market.
Increasing Cases of Arrhythmia and Bradycardia in Malaysia
Arrhythmia
and bradycardia are two heart conditions that are becoming increasingly
prevalent in Malaysia. Arrhythmia is a condition where the heart beats
irregularly or too quickly, while bradycardia is a condition where the heart beats
too slowly. Both conditions can lead to serious health complications if left
untreated.
One of
the primary reasons for the increasing incidence of arrhythmia and bradycardia
in Malaysia is the aging population. As people get older, the risk of developing
heart problems increases. According to the World Health Organization (WHO),
the percentage of people aged 65 years and older in Malaysia is expected to
increase from 5.1% in 2020 to 9.9% in 2050. This demographic shift is
likely to result in a higher prevalence of heart conditions such as arrhythmia
and bradycardia.
Another
contributing factor is the lifestyle changes in Malaysia, such as a sedentary
lifestyle, poor diet, and increasing stress levels. These factors can increase
the risk of developing cardiovascular disease, which, in turn, increases the
likelihood of developing arrhythmia or bradycardia.
Arrhythmia
and bradycardia can have serious consequences if left untreated. Arrhythmia can
lead to blood clots, stroke (according to a 2020 data by WHO, stroke deaths
in Malaysia accounted for 12.85% of total deaths), heart failure, and even
sudden cardiac arrest. Bradycardia, on the other hand, can lead to fatigue,
dizziness, fainting, and shortness of breath. In severe cases, bradycardia can
also lead to cardiac arrest.
The
increasing incidence of arrhythmia and bradycardia in Malaysia is also putting
a strain on the country's healthcare system. The cost of treatment for these
conditions can be high, especially for patients who require long-term care.
This can be a burden on both the patients and their families.
Preventing
arrhythmia and bradycardia involves making lifestyle changes such as adopting a
healthy diet, exercising regularly, reducing stress, and quitting smoking.
Early detection is also essential, and patients who have a family history of
heart disease or experience symptoms such as palpitations, dizziness, or
shortness of breath should seek medical attention promptly.
Treatment
for arrhythmia and bradycardia in Malaysia typically involves medication,
lifestyle changes, and in severe cases, the use of pacemakers or implantable
cardioverter-defibrillators (ICDs), thereby fuelling the Malaysia pacemaker market.
Advances in Technology
Pacemakers
are small electronic devices that are implanted under the skin of the chest to
help regulate an irregular heartbeat. These are life-saving devices for
millions of people across the world, and these have been in use for several
decades. However, over the years, technological advancements have led to
significant improvements in pacemaker technology, making them more effective
and efficient than ever before. Some of the technological advancements in
pacemakers are:
- Smaller
size and longer battery life: One of the most significant technological
advancements in pacemakers is their smaller size and longer battery life. Earlier,
pacemakers were bulky and required frequent battery replacements. However,
modern pacemakers are much smaller and can last up to 10 years or more,
reducing the need for frequent surgeries. In fact, the Institute Jantung
Negara Sdn Bhd (IJN), better known as National Heart Institute, Kuala Lumpur,
Malaysia became the first hospital outside the United States to successfully
implant the world’s smallest pacemaker with atrioventricular (AV) synchrony
named Micra AV by Medtronic Inc. in 2020.
- Dual-chamber
pacemakers: Dual-chamber pacemakers are devices that can sense and pace both
the upper and lower chambers of the heart. This technology has significantly
improved the effectiveness of pacemakers, as it allows for more precise control
of the heartbeat.
- Remote
monitoring: Remote monitoring is a recent advancement in pacemaker technology
that allows doctors to monitor pacemaker performance and patient health
remotely. Patients with remote monitoring-enabled pacemakers can transmit data
to their healthcare providers via the internet, allowing for more frequent
monitoring and faster response times.
- MRI
compatibility: Earlier pacemakers were not compatible with MRI machines, making
it challenging for patients who required MRI scans. However, modern pacemakers
are MRI compatible, allowing patients to undergo MRI scans without any risk of
interference.
- Leadless
pacemakers: Leadless pacemakers are a recent innovation in pacemaker
technology. Unlike traditional pacemakers, leadless pacemakers are inserted
directly into the heart and do not require leads or wires. They are smaller,
safer, and more comfortable than traditional pacemakers.
Furthermore,
the usage of cardiac resynchronization therapy device pacemaker (CRT-P) devices
in Malaysia has increased significantly over the past few years. A CRT-P device
is a small electronic device that is implanted under the skin in the chest
area. It is similar to a traditional pacemaker but has additional features that
help to synchronize the contractions of the heart's ventricles. This improves
the heart's pumping ability and helps to reduce symptoms of heart failure such
as fatigue, shortness of breath, and swelling in the legs.
Cardiac
resynchronization therapy (CRT) is a treatment option for people with heart
failure who have a specific type of abnormal heartbeat. This treatment involves
the use of a CRT-P to help regulate the heartbeat and improve the patient's
quality of life.
Surge in Elderly Population in Malaysia
Malaysia,
like many other countries around the world, is experiencing a significant
demographic shift with a growing geriatric population. This is due to a
combination of factors, including advancements in healthcare, improved living
standards, and a decrease in birth rates.
The
geriatric population in Malaysia is defined as individuals aged 60 and above. According
to the Department of Statistics Malaysia, the geriatric population in Malaysia
is projected to reach 9.9 million by 2040, accounting for approximately 25% of
the total population. This is a significant increase from the 2019 figure of
3.3 million geriatric individuals, which accounted for 10.2% of the total
population.
The
growing geriatric population in Malaysia has several implications, including:
Increased
healthcare needs: As individuals age, they are more likely to develop chronic
health conditions that require ongoing medical care. This puts a strain on the
healthcare system, as there are more patients requiring medical attention.
Increased
demand for elderly care services: As the geriatric population grows, there is
an increased demand for elderly care services, such as assisted living
facilities, nursing homes, and home care services.
Economic
implications: An aging population can have economic implications, such as
increased healthcare costs, decreased productivity, and increased dependency
ratios.
Download Free Sample Report
Market Segmentation
The Malaysia
pacemaker market can be segmented by type, application, end user, source, and by
region. Based on type, the market can be divided into diagnostic &
monitoring devices and surgical devices. Based on application, the market can
be segmented into coronary artery disease, cardiac arrhythmia, heart failure, and
others. Based on end user, the market can be fragmented into hospitals & clinics,
diagnostic centers, and others. Based on source, the market can be split into import
and domestic.
Market Players
Medtronic Malaysia
Sdn Bhd, Boston Scientific Medical Device (Malaysia) Sdn. Bhd., BIOTRONIK
Medical Devices (Malaysia) SDN BHD, Abbott Malaysia Sdn Bhd, and Osypka Medical
Asia Pacific Sdn Bhd, are some of the leading players operating in the Malaysia
pacemaker market.
|
Attribute
|
Details
|
|
Base Year
|
2022
|
|
Historic Data
|
2018 – 2021
|
|
Estimated Year
|
2023
|
|
Forecast
Period
|
2024 – 2028
|
|
Quantitative Units
|
Revenue in USD Million, Volume
in Million Units and CAGR for 2018-2022 and 2023-2028
|
|
Report Coverage
|
Revenue forecast, company share,
competitive landscape, growth factors, and trends
|
|
Segments Covered
|
By Type
By Technology
By Product Type
By Application
By End User
By Region
|
|
Regional scope
|
West and East
|
|
Key companies profiled
|
Medtronic Malaysia Sdn Bhd,
Boston Scientific Medical Device (Malaysia) Sdn. Bhd., BIOTRONIK Medical
Devices (Malaysia) SDN BHD, Abbott Malaysia Sdn Bhd, Osypka Medical Asia
Pacific Sdn Bhd
|
|
Customization
scope
|
10% free report customization with
purchase. Addition or alteration to country, regional & segment scope.
|
|
Pricing and purchase options
|
Avail customized purchase
options to meet your exact research needs. Explore purchase options
|
|
Delivery
Format
|
PDF and Excel through Email (We can also
provide the editable version of the report in PPT/Word format on special
request)
|
Report
Scope:
In this
report, the Malaysia pacemaker market has been segmented into following
categories, in addition to the industry trends which have also been detailed
below:
- Malaysia Pacemaker Market, By Type:
o Implantable
o External
- Malaysia Pacemaker Market, By Technology:
o Dual Chamber
o Single Chamber
o Biventricular Chamber
- Malaysia Pacemaker Market, By Product
Type:
o MRI Compatible
o Conventional
- Malaysia
Pacemaker Market,
By Application:
o Arrythmias
o Congestive Heart Failure
o Others
- Malaysia
Pacemaker Market,
By End User:
o Hospitals
o Cardiac Care Centers
o Ambulatory Surgical Centers
- Malaysia
Pacemaker Market,
By Region:
o West
o East
Competitive
Landscape
Company
Profiles: Detailed analysis of the major
companies present in the Malaysia pacemaker market.
Available
Customizations:
With
the given market data, TechSci Research offers customizations according to a
company’s specific needs. The following customization options are available for
the report:
Company
Information
- Detailed analysis and profiling of
additional market players (up to five).
Malaysia pacemaker market is an upcoming report to be released soon. If you
wish an early delivery of this report or want to confirm the date of release,
please contact us at [email protected]